$2.89 Billion is the total value of Avoro Capital Advisors LLC's 35 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 40.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRTX | MIRATI THERAPEUTICS INC | $397,838,000 | +40.5% | 3,862,500 | 0.0% | 13.75% | +12.3% | |
| IMMU | Buy | IMMUNOMEDICS INC | $291,270,000 | -14.4% | 21,000,000 | +18.5% | 10.07% | -31.6% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $263,653,000 | +163.3% | 10,752,585 | +2.1% | 9.11% | +110.4% |
| ASND | Buy | ASCENDIS PHARMAsponsored adr | $226,846,000 | +7.4% | 1,970,000 | +9.7% | 7.84% | -14.2% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $212,730,000 | +49.4% | 1,400,000 | +17.2% | 7.35% | +19.4% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $181,150,000 | +82.1% | 2,115,000 | +88.8% | 6.26% | +45.6% |
| AMRN | Sell | AMARIN CORP PLCsponsored adr | $145,425,000 | -12.4% | 7,500,000 | -6.2% | 5.03% | -30.0% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $124,800,000 | -3.4% | 10,000,000 | +5.3% | 4.31% | -22.8% |
| ARGX | ARGENX SEsponsored adr | $118,927,000 | +13.4% | 840,000 | 0.0% | 4.11% | -9.3% | |
| ZGNX | Buy | ZOGENIX INC | $96,755,000 | -8.2% | 2,025,000 | +5.7% | 3.34% | -26.6% |
| HZNP | New | HORIZON THERAPEUTICS PLC | $96,240,000 | – | 4,000,000 | +100.0% | 3.33% | – |
| ARRY | ARRAY BIOPHARMA INC | $92,660,000 | +90.0% | 2,000,000 | 0.0% | 3.20% | +51.9% | |
| ATNX | New | ATHENEX INC | $91,179,000 | – | 4,605,000 | +100.0% | 3.15% | – |
| TCDA | Buy | TRICIDA INC | $86,812,000 | +32.2% | 2,200,000 | +29.4% | 3.00% | +5.7% |
| MYOK | Buy | MYOKARDIA INC | $68,943,000 | +32.6% | 1,375,000 | +37.5% | 2.38% | +6.0% |
| GBT | GLOBAL BLOOD THERAPEUTICS INC | $49,970,000 | -0.6% | 950,000 | 0.0% | 1.73% | -20.6% | |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $41,615,000 | – | 3,500,000 | +100.0% | 1.44% | – |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $37,732,000 | -2.8% | 360,000 | +16.1% | 1.30% | -22.3% |
| ACAD | ACADIA PHARMACEUTICALS INC | $35,417,000 | -0.4% | 1,325,000 | 0.0% | 1.22% | -20.4% | |
| BDSI | BIODELIVERY SCIENCES INTL | $34,526,000 | -12.3% | 7,424,867 | 0.0% | 1.19% | -29.8% | |
| MDCO | Sell | MEDICINES CO | $33,735,000 | -22.7% | 925,000 | -40.8% | 1.17% | -38.2% |
| PTCT | New | PTC THERAPEUTICS INC | $30,780,000 | – | 684,000 | +100.0% | 1.06% | – |
| ALLO | ALLOGENE THERAPEUTICS INC | $30,303,000 | +1.7% | 1,128,594 | 0.0% | 1.05% | -18.6% | |
| XENE | XENON PHARMACEUTICALS INC | $23,664,000 | -3.0% | 2,400,000 | 0.0% | 0.82% | -22.4% | |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $19,332,000 | +100.8% | 2,700,000 | +272.4% | 0.67% | +60.6% |
| PCRX | PACIRA BIOSCIENCES INC | $17,396,000 | +14.3% | 400,000 | 0.0% | 0.60% | -8.7% | |
| ADPT | New | ADAPTIVE BIOTECHNOLOGIES | $9,660,000 | – | 200,000 | +100.0% | 0.33% | – |
| KOD | Sell | KODIAK SCIENCES INC | $6,751,000 | +64.9% | 577,021 | -8.0% | 0.23% | +31.6% |
| ALIM | ALIMERA SCIENCES INC | $5,554,000 | -16.0% | 6,240,000 | 0.0% | 0.19% | -32.9% | |
| SRPT | New | SAREPTA THERAPEUTICS INCcall | $5,463,000 | – | 250,000 | +100.0% | 0.19% | – |
| FENC | FENNEC PHARMACEUTICALS INC | $4,424,000 | -17.5% | 1,105,999 | 0.0% | 0.15% | -34.1% | |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $4,286,000 | – | 285,714 | +100.0% | 0.15% | – |
| Sell | INTEC PHARMA LTD | $3,559,000 | -80.6% | 820,000 | -67.2% | 0.12% | -84.5% | |
| TLGT | TELIGENT INC | $3,296,000 | -45.7% | 5,231,206 | 0.0% | 0.11% | -56.5% | |
| IWM | New | iShares Russell 2000put | $110,000 | – | 250,000 | +100.0% | 0.00% | – |
| OTLK | Exit | OUTLOOK THERAPEUTICS INC | $0 | – | -84,999 | -100.0% | -0.03% | – |
| XBI | Exit | SPDR SERIES TRUST - S&P BIOTECHput | $0 | – | -1,000,000 | -100.0% | -0.06% | – |
| ESTA | Exit | ESTABLISHMENT LABS HOLDINGS INC | $0 | – | -475,000 | -100.0% | -0.49% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -900,000 | -100.0% | -0.77% | – |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -4,000,000 | -100.0% | -4.57% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 36 | Q3 2023 | 17.9% |
| MIRATI THERAPEUTICS INC. | 35 | Q3 2023 | 17.2% |
| BIOMARIN PHARMACEUTICAL INC | 31 | Q3 2023 | 8.0% |
| SAREPTA THERAPUTICS INC | 28 | Q3 2023 | 14.8% |
| ASCENDIS PHARMA | 28 | Q3 2023 | 9.1% |
| ARGENX SE | 26 | Q3 2023 | 9.5% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
| FENNEC PHARMACEUTICALS INC | 25 | Q3 2023 | 0.4% |
| MADRIGAL PHARMACEUTICALS INC | 22 | Q3 2023 | 7.2% |
| XENON PHARMACEUTICALS INC | 22 | Q3 2023 | 3.3% |
View Avoro Capital Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| DICE Therapeutics, Inc. | February 14, 2023 | 2,525,555 | 5.3% |
| IOVANCE BIOTHERAPEUTICS, INC. | February 14, 2023 | 7,020,000 | 4.4% |
| IVERIC bio, Inc. | February 14, 2023 | 6,750,000 | 5.0% |
| Kura Oncology, Inc. | February 14, 2023 | 3,105,000 | 4.5% |
| Aadi Bioscience, Inc. | September 26, 2022 | 2,849,402 | 11.7% |
| ARENA PHARMACEUTICALS INC | February 11, 2022 | 1,235,000 | 2.0% |
| AVADEL PHARMACEUTICALS PLC | February 11, 2022 | 1,670,000 | 2.9% |
| FENNEC PHARMACEUTICALS INC. | February 11, 2022 | 1,200,000 | 4.6% |
| POINT Biopharma Global Inc.Sold out | February 11, 2022 | 0 | 0.0% |
View Avoro Capital Advisors LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-23 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Avoro Capital Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.